Some in the gene therapy field lament lost time while Capsida kept silent about the brain receptor it was targeting when things went wrong.
Photo illustration: STAT; Photo: Adobe
By Jason Mast
May 12, 2026
General Assignment Reporter
Jason Mast
Encoded Therapeutics gives a heads-up to other gene therapy company about the trade-offs with a drug meant to improve safety.
Doctors have linked a boy's tumor to a gene therapy, but say the rare risks need to be weighed against the profound benefits such…
Some boys had astonishing recoveries. But other boys died. Now Astellas is returning to revised gene therapy for XLMTM.
Alzheimer's drug rollout letdown, a China-based heart drug startup, and more biotech news from The Readout
The case for Makary as the WOAT, Cassidy's seat at risk ahead of midterms, and other biotech news from The Readout
Vinay Prasad's acting replacement, remembering genomics pioneer J. Craig Venter, and more biotech news from The Readout
